Barouche F - Search Results

1

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.

Wolkin A, Barouche F, Wolf AP, Rotrosen J, Fowler JS, Shiue CY, Cooper TB, Brodie JD. Wolkin A, et al. Among authors: barouche f. Am J Psychiatry. 1989 Jul;146(7):905-8. doi: 10.1176/ajp.146.7.905. Am J Psychiatry. 1989. PMID: 2568094

2

Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.

Bartlett EJ, Barouche F, Brodie JD, Wolkin A, Angrist B, Rotrosen J, Wolf AP. Bartlett EJ, et al. Among authors: barouche f. Psychiatry Res. 1991 May;40(1):11-20. doi: 10.1016/0925-4927(91)90025-l. Psychiatry Res. 1991. PMID: 1946838 Free article.

3

Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.

Smith M, Wolf AP, Brodie JD, Arnett CD, Barouche F, Shiue CY, Fowler JS, Russell JA, MacGregor RR, Wolkin A, et al. Smith M, et al. Among authors: barouche f. Biol Psychiatry. 1988 Apr 1;23(7):653-63. doi: 10.1016/0006-3223(88)90048-0. Biol Psychiatry. 1988. PMID: 2967093

4

Dopamine receptor occupancy and plasma haloperidol levels.

Wolkin A, Brodie JD, Barouche F, Rotrosen J, Wolf AP, Smith M, Fowler J, Cooper TB. Wolkin A, et al. Among authors: barouche f. Arch Gen Psychiatry. 1989 May;46(5):482-4. doi: 10.1001/archpsyc.1989.01810050096021. Arch Gen Psychiatry. 1989. PMID: 2785373 No abstract available.

5

Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects.

Peselow ED, Robins C, Block P, Barouche F, Fieve RR. Peselow ED, et al. Among authors: barouche f. Am J Psychiatry. 1990 Apr;147(4):439-44. doi: 10.1176/ajp.147.4.439. Am J Psychiatry. 1990. PMID: 2180328 Clinical Trial.

6

The predictive value of the dexamethasone suppression test. A placebo-controlled study.

Peselow ED, Stanley M, Filippi AM, Barouche F, Goodnick P, Fieve RR. Peselow ED, et al. Among authors: barouche f. Br J Psychiatry. 1989 Nov;155:667-72. doi: 10.1192/s0007125000018171. Br J Psychiatry. 1989. PMID: 2532946 Clinical Trial.

7

The dexamethasone suppression test as a monitor of clinical recovery.

Peselow ED, Baxter N, Fieve RR, Barouche F. Peselow ED, et al. Among authors: barouche f. Am J Psychiatry. 1987 Jan;144(1):30-5. doi: 10.1176/ajp.144.1.30. Am J Psychiatry. 1987. PMID: 3799836

8

Pattern analysis of antidepressant response to fluoxetine.

Fieve RR, Goodnick PJ, Peselow ED, Barouche F, Schlegel A. Fieve RR, et al. Among authors: barouche f. J Clin Psychiatry. 1986 Nov;47(11):560-2. J Clin Psychiatry. 1986. PMID: 3533909 Clinical Trial.

9

Dexamethasone suppression test in predicting response to tricyclic antidepressants in depressed outpatients.

Peselow ED, Goldring N, Barouche F, Fieve RR. Peselow ED, et al. Among authors: barouche f. Psychopathology. 1985;18(4):206-11. doi: 10.1159/000284406. Psychopathology. 1985. PMID: 4089119

10

The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients.

Peselow ED, Goldring N, Stanley M, Barouche F, Fieve RR. Peselow ED, et al. Among authors: barouche f. Int Clin Psychopharmacol. 1986 Jan;1(1):17-23. doi: 10.1097/00004850-198601000-00003. Int Clin Psychopharmacol. 1986. PMID: 3549869 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters